Related Experiment Video
Updated: Oct 23, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Distinct mutational status in GATA3-Positive clear cell adenocarcinoma of the urinary tract: A CASE report
Hala Abdelwahab1, Derek Friedman2, Andrea Lightle1
1Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY, USA.
Abstract:
•Clear cell adenocarcinoma of the lower urinary tract is rare and poses diagnostic challenge.•GATA3, which is frequently expressed in urothelial carcinoma, can be expressed in clear cell adenocarcinoma.•ARID1A, PBRM1, ERBB4, and SMARCA4 mutations were identified in the current CASE.•Molecular studies may aid in the diagnosis, and optimal treatment decision-making process.
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management

